comparemela.com

Latest Breaking News On - National medical products - Page 17 : comparemela.com

CARsgen Announces NDA Acceptance of BCMA CAR T Zevor-cel (CT053) by China NMPA

SHANGHAI, Oct. 18, 2022 /PRNewswire/ CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell th.

United statesWenming chenZonghai liChengcheng fuAmerican society of clinical oncologyCarsgen therapeutics holdingsPrnewswire carsgen therapeutics holdings limited stock codeCapital medical universityWorld health organizationDrug administrationMarket researchHematology departmentInternational agency for research on cancerEuropean medicines agencyNational medical products administrationFirst affiliated hospital of soochow university

Biogen Announces EMA Acceptance Of Tocilizumab Biosimilar Application - Life Sciences, Biotechnology & Nanotechnology

Biogen Inc. ("Biogen") recently announced that the European Medicines Agency (EMA) has accepted the marketing authorization application for BIIB800 (BAT1806).

Ian henshawBio thera solutions ltdEuropean medicines agencyBiogen incChina national medical productsBio thera solutionsNational medical productsBio thera solutionsLife sciencesLife sciencesIotechnology amp nanotechnology

China s State Council appoints, removes officials-Xinhua

China s State Council appoints, removes officials-

Zhou jinqiangShao xinyuDong zhiyiZhao chongjiuGao xiaobingChen jinfuYan jiangyingMa junshengAdministration of sport chinaNational medical products administrationNational healthcare security administrationNational immigration administrationCivil aviation administration of chinaState councilGeneral administrationState post bureau

Needle-Free Injection Device Market– What Will Be The Future Scope Till 2030?

Pune, Maharashtra, September 16 2022 (Wiredrelease) Market.Biz –:Trends In Needle-Free Injection Device Market Shaping The Industry Till 2030The Needle-Free Injection Device industry has seen tremendous growth over the past few years and the outlook for 2022 is positive. The industry is projected to reach trillions.

United statesInjex pharmaAntares pharmaIndustry researchInternational technologiesNational medical productsCrossject medical technologyWiredrelease news departmentMarket bizNeedle free injection deviceFor better understandingAre the currentDevelopments in theIndustry report needle free injection deviceLiquid injectionsCosmetic surgery

For first time, Covid vaccine that is inhaled being used in China

CanSino Biologics has announced that its recently developed COVID-19 vaccine has been approved by China's drug regulator for emergency use as a booster

Cansino biologicsNational medical products administrationLivzon pharmaceutical groupNational medical productsMainland chinaCansino biologicsCovid 19 vaccineHina 39s drug regulatorEmergency use

vimarsana © 2020. All Rights Reserved.